Related Experiment Video
Updated: Jan 22, 2026

A MRI-Based Toolbox for Neurosurgical Planning in Nonhuman Primates
Published on: July 17, 2020
Mn(II) compounds as an alternative to Gd-based MRI probes
Mauro Botta1, Fabio Carniato1, David Esteban-Gómez2
1Dipartimento di Scienze e Innovazione Tecnologica, Università del Piemonte Orientale 'A. Avogadro', Viale T. Michel 11, 15121 Piedmont, Italy.
Manganese (II) compounds show promise as safer MRI contrast agents, offering advantages over gadolinium (III)-based agents. Research is ongoing to optimize their properties for enhanced MRI imaging and stability.
Area of Science:
- Medical Imaging
- Materials Science
- Biochemistry
Background:
- Gadolinium (III)-based agents are standard for MRI, but concerns exist regarding toxicity and long-term effects.
- Manganese (II) presents favorable physicochemical and toxicity profiles, making it a potential alternative contrast agent.
- The field of manganese (II) contrast agents is rapidly evolving, with ongoing research into novel compounds and systems.
Purpose of the Study:
- To critically review the chemical and magnetic properties of Mn(II) compounds for MRI applications.
- To explore strategies for optimizing the efficiency of Mn(II) MRI probes.
- To discuss key challenges concerning the stability and kinetic inertness of Mn(II) contrast agents.
Main Methods:
- Literature review of Mn(II) compounds and their application as MRI contrast agents.
- Analysis of chemical and magnetic properties relevant to relaxivity.
- Evaluation of molecular parameters influencing relaxation processes.
- Assessment of stability and kinetic inertness studies.
Main Results:
- Mn(II) compounds, including small complexes and nanosystems, exhibit potential as MRI contrast agents.
- Understanding molecular parameters is crucial for optimizing relaxivity and imaging efficiency.
- Stability and kinetic inertness remain critical considerations for clinical translation.
Conclusions:
- Mn(II) represents a promising avenue for developing safer and effective MRI contrast agents.
- Further research into optimizing Mn(II) probe design is essential for clinical viability.
- Addressing stability and inertness challenges will be key to successful implementation.
Related Concept Videos
Coordination Compounds and Nomenclature
Organic Compounds
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Classification of Elements and Compounds
Compounds are pure substances composed of two or more elements in fixed, definite proportions. Compounds are classified as ionic or molecular (covalent) based on the bonds...
Molecules and Compounds
Null and Alternative Hypotheses
The null hypothesis, denoted by H0 is a statement of no difference between the variables—they are not related. This can often be considered the status quo. As a result if you cannot accept the null, it requires some action.
The alternative hypothesis, denoted by H1 or Ha, is a claim about the...

